Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulodexide in Type 2 Diabetes and Microalbuminuria
NCT00130208Phase 3Completed
- Sponsor
- Keryx Biopharmaceuticals, Inc.
- Start
- Aug 2005
- Primary completion
- Jan 2008
- Countries
- 3
01
Overview
A Phase 3 trial of sulodexide in diabetic nephropathy (DN), sponsored by Keryx Biopharmaceuticals, Inc.. Started Aug 2005; status: completed.
02
Drugs
sulodexide
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00130208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130208.